TipRanks on MSN

GSK advances share buyback strategy with acquisition of 235,000 shares

GSK announced the recent purchase of 235,000 of its ordinary shares, as part of its ongoing share buyback program. The repurchased shares, with a volume-weighted average price of 1,841.56p per share, ...
TipRanks on MSN

GSK’s SPHERE study completes: A new horizon for pediatric HES treatment

GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) has completed a significant clinical study ...
PharmiWeb

GSK’s Exdensur Gains US FDA Approval for Severe Asthma Treatment

GSK’s Exdensur is approved by the US FDA as a twice-yearly add-on treatment for severe eosinophilic asthma in patients 12 and ...
Penn Live

Drug maker GlaxoSmithKline schedules closing of Carlisle manufacturing facility

CARLISLE - GlaxoSmithKline, one of the world’s largest pharmaceutical companies, confirmed Monday that it will close a manufacturing facility in Carlisle next year. Production in Carlisle will end by ...